0001628280-23-000082.txt : 20230103 0001628280-23-000082.hdr.sgml : 20230103 20230103161146 ACCESSION NUMBER: 0001628280-23-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221230 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Almenoff June Sherie CENTRAL INDEX KEY: 0001492647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 23502202 MAIL ADDRESS: STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC. STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 wf-form4_167278029177365.xml FORM 4 X0306 4 2022-12-30 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001492647 Almenoff June Sherie C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 0 0 0 Stock Option (Right to Buy) 5.0401 2022-12-30 4 A 0 410 0 A 2022-12-30 2032-12-30 Common Stock 410.0 410 D 100% of the stock option will immediately vest on the date that it is granted. /s/ Jennifer Zoltoski, by Power of Attorney 2023-01-03